Maria Fe Paz

Rosetta Genomics has appointed Maria Fe Paz as interim chief medical officer with plans to transition her to chief medical officer upon receipt of a valid work visa that supports her planned relocation to the US. Paz joins Rosetta Genomics from Labceutics were she was the founder-president and the Diaceutics Group where she served as chief medical officer. Prior to joining Diaceutics and founding Labceutics, she served as head of translational medicine and scientific development at Zeltia. Paz's earlier experience includes founding and serving as the scientific-medical consultant for Epicure Molecular, serving as head of the epigenetics unit at the Spanish National Cardiovascular Center, and she was founder and director of molecular and genetic diagnostics laboratories in Hospital de Madrid.